In this study, we established a virus-mediated Cas9/dual-sgRNA-mediated disruption of the BCR-ABL fusion gene that could significantly reduce Ph expression and abolish leukemia cell survival and tumorigenic abilitiesin vitro andex vivo. The gene discussed is ABL1; the disease is leukemia.